Department of Chemistry and Chemical Biology, Harvard University, Cambridge, United States.
Harvard-MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, United States.
Elife. 2018 Feb 14;7:e33038. doi: 10.7554/eLife.33038.
Eliciting antibodies that are cross reactive with surface proteins of diverse strains of highly mutable pathogens (e.g., HIV, influenza) could be key for developing effective universal vaccines. Mutations in the framework regions of such broadly neutralizing antibodies (bnAbs) have been reported to play a role in determining their properties. We used molecular dynamics simulations and models of affinity maturation to study specific bnAbs against HIV. Our results suggest that there are different classes of evolutionary lineages for the bnAbs. If germline B cells that initiate affinity maturation have high affinity for the conserved residues of the targeted epitope, framework mutations increase antibody rigidity as affinity maturation progresses to evolve bnAbs. If the germline B cells exhibit weak/moderate affinity for conserved residues, an initial increase in flexibility via framework mutations may be required for the evolution of bnAbs. Subsequent mutations that increase rigidity result in highly potent bnAbs. Implications of our results for immunogen design are discussed.
诱导针对高度易变病原体(如 HIV、流感)表面蛋白具有交叉反应性的抗体可能是开发有效通用疫苗的关键。据报道,此类广泛中和抗体(bnAb)框架区的突变在决定其特性方面发挥作用。我们使用分子动力学模拟和亲和力成熟模型来研究针对 HIV 的特定 bnAb。我们的研究结果表明,bnAb 存在不同的进化谱系类别。如果起始亲和力成熟的原始 B 细胞对靶表位的保守残基具有高亲和力,那么随着亲和力成熟的进行,框架突变会增加抗体的刚性,从而进化出 bnAb。如果原始 B 细胞对保守残基表现出弱/中等亲和力,则可能需要通过框架突变来增加初始灵活性,从而进化出 bnAb。随后增加刚性的突变会导致产生高效的 bnAb。我们的研究结果对免疫原设计具有启示意义。